The use of arfonad for the alleviation of cardio-vascular stress following electro-convulsive therapy.
D001337:Autonomic Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology*; D003295:Convulsive Therapy; D004565:Electroconvulsive Therapy / Q000150:complications*; D014294:Trimethaphan
D001337:Autonomic Agents; D014294:Trimethaphan; C017774:trimethaphan camsylate
AUTONOMIC DRUGS/therapeutic use; CARDIOVASCULAR DISEASES/etiology and pathogenesis; SHOCK THERAPY, ELECTRIC/complications